@article{ATM12204,
author = {Kalyan Ram Bhamidimarri},
title = {Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4–5 chronic kidney disease},
journal = {Annals of Translational Medicine},
volume = {4},
number = {Suppl 1},
year = {2016},
keywords = {},
abstract = {The prevalence of Hepatitis C (HCV) in patients with advanced renal disease and dialysis is higher than that of general population with rates around 5–10% in Europe and USA (1,2).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/12204}
}